The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final overall survival (OS) analysis of an international randomized trial evaluating bevacizumab (BEV) in the primary treatment of advanced ovarian cancer: A NRG oncology/Gynecologic Oncology Group (GOG) study.
 
Robert Allen Burger
Honoraria - Expertix
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; Gradalis; Immunogen; InVitae; Janssen Research & Development; Merck; Morphotek; Regeneron; Tesaro; VBL Therapeutics
 
Danielle Enserro
No Relationships to Disclose
 
Krishnansu Sujata Tewari
Consulting or Advisory Role - Roche/Genentech
Speakers' Bureau - AstraZeneca; Merck; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Mark F. Brady
Consulting or Advisory Role - Aeterna Zentaris; Cel-Sci; Endocyte
 
Michael A. Bookman
Employment - McKesson; PharmAbcine
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Clovis Oncology; Endocyte; Gradalis; Immunogen; Mateon Therapeutics; Novartis; Pfizer; Tesaro; Vertex
 
Gini F. Fleming
Research Funding - Corcept Therapeutics (Inst)
 
Helen Q Huang
No Relationships to Disclose
 
Howard D. Homesley
No Relationships to Disclose
 
Jeffrey Fowler
No Relationships to Disclose
 
Matthew Boente
Employment - Roche/Genentech
Stock and Other Ownership Interests - Genentech/Roche
Speakers' Bureau - Clovis Oncology
Travel, Accommodations, Expenses - Clovis Oncology
 
Leslie M. Randall
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Immunogen
Speakers' Bureau - AstraZeneca
Research Funding - Array BioPharma (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Mateon Therapeutics (Inst); On Target Laboratories (Inst); Pfizer (Inst); PPD (Inst)
 
John K. Chan
Honoraria - AstraZeneca; Clovis Oncology; Genentech/Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Biodesix; Clovis Oncology; Janssen Oncology; Mateon Therapeutics; Roche/Genentech; Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; Roche/Genentech; Tesaro
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; Roche/Genentech; Tesaro
 
James Stuart Ferris
No Relationships to Disclose
 
Philip J. DiSaia
No Relationships to Disclose
 
Larry J. Copeland
Consulting or Advisory Role - Clovis Oncology; Immunogen; Janssen Oncology; Tesaro; Tesaro
Expert Testimony - Johnson & Johnson
 
Robert S. Mannel
Consulting or Advisory Role - Clovis Oncology (Inst); Tesaro (Inst)
 
Michael J. Birrer
Consulting or Advisory Role - Acceleron Pharma; Merrimack; Oxigene; Roche/Genentech; Sanofi; Threshold Pharmaceuticals
 
Bradley J. Monk
Leadership - US Oncology
Honoraria - Abbvie; Advaxis; Amgen; AstraZeneca; Bayer; Biodesix; Cerulean Pharma; Clovis Oncology; GlaxoSmithKline; Gradalis; Immunogen; Incyte; Insys Therapeutics; Janssen; Mateon Therapeutics; Merck; Myriad Pharmaceuticals; Nucana; Oxigene; Oxigene; Perthera; Pfizer; Precision Oncology; Roche/Genentech; Tesaro; Verastem; Vermillion
Consulting or Advisory Role - Abbvie; Advaxis; Amgen; AstraZeneca; Bayer; Biodesix; Cerulean Pharma; Clovis Oncology; GlaxoSmithKline; Gradalis; Immunogen; Incyte; Insys Therapeutics; Mateon Therapeutics; Merck; Myriad Pharmaceuticals; Nucana; Oxigene; Perthera; Pfizer; Precision Oncology; Roche/Genentech; Tesaro; Verastem; Vermillion
Speakers' Bureau - AstraZeneca; Clovis Oncology; Janssen; Roche/Genentech; Tesaro
Research Funding - Advaxis (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Regeneron (Inst); Tesaro (Inst)